| scholarly article | Q13442814 |
| P2093 | author name string | Y Huang | |
| L Zhang | |||
| D D Ho | |||
| P2860 | cites work | How does HIV cause AIDS? | Q22242244 |
| Serine phosphorylation-independent downregulation of cell-surface CD4 by nef | Q22251290 | ||
| Phylogenies from molecular sequences: inference and reliability | Q28289703 | ||
| Analysis and prediction of the different types of beta-turn in proteins | Q28292391 | ||
| Fast and sensitive multiple sequence alignments on a microcomputer | Q29618252 | ||
| Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 | ||
| Human immunodeficiency virus type 1 negative factor is a transcriptional silencer | Q33836630 | ||
| Human immunodeficiency virus type 1 nef quasispecies in pathological tissue | Q33934796 | ||
| Structure of simian immunodeficiency virus regulatory genes | Q34284560 | ||
| Lack of a negative influence on viral growth by the nef gene of human immunodeficiency virus type 1. | Q34323971 | ||
| Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor | Q34323995 | ||
| Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication | Q34603122 | ||
| A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study | Q34998944 | ||
| Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III. | Q35564616 | ||
| The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages | Q36362652 | ||
| CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals | Q36363328 | ||
| Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. | Q36633274 | ||
| Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo | Q36650992 | ||
| Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro | Q36687926 | ||
| Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line | Q36732916 | ||
| Mutational analysis of the human immunodeficiency virus type 2 (HIV-2) genome in relation to HIV-1 and simian immunodeficiency virus SIV (AGM). | Q36800949 | ||
| Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers | Q36801268 | ||
| Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 | Q36806618 | ||
| Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates | Q36827410 | ||
| Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression | Q36830303 | ||
| Expression of the type 1 human immunodeficiency virus Nef protein in T cells prevents antigen receptor-mediated induction of interleukin 2 mRNA. | Q37532727 | ||
| Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the numbers of CD4+ lymphocytes | Q37558815 | ||
| Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. | Q40061126 | ||
| The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. | Q41531784 | ||
| Effect of nef Alleles on Replication of Human Immunodeficiency Virus Type 1 | Q41558492 | ||
| Effect of myristoylation on p27nef subcellular distribution and suppression of HIV-LTR transcription | Q41635961 | ||
| Differential effects of nef on HIV replication: implications for viral pathogenesis in the host | Q41757870 | ||
| The importance of nef in the induction of human immunodeficiency virus type 1 replication from primary quiescent CD4 lymphocytes. | Q41768724 | ||
| Incubation period of AIDS in San Francisco | Q43953969 | ||
| Rapid clinical and laboratory progression of HIV infection | Q44760004 | ||
| Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. | Q45780550 | ||
| Quantitation of human immunodeficiency virus type 1 in the blood of infected persons | Q45844274 | ||
| Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease | Q45853529 | ||
| Long-Term Human Immunodeficiency Virus Infection in Asymptomatic Homosexual and Bisexual Men with Normal CD4+ Lymphocyte Counts: Immunologic and Virologic Characteristics | Q45860674 | ||
| Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes | Q45866982 | ||
| Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates | Q54195861 | ||
| In vivo derived HIV-1 nef gene products are heterogeneous and lack detectable nucleotide binding activity | Q54679703 | ||
| Long-term symptomless HIV-1 infection in recipients of blood products from a single donor | Q57076560 | ||
| Nef protein of HIV-1 is a transcriptional repressor of HIV-1 LTR | Q68097623 | ||
| Summary of the epidemiology of HIV/AIDS in Japan | Q72549557 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 93-100 | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection | |
| P478 | volume | 69 |
| Q73358372 | A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci |
| Q28768294 | A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. |
| Q24598018 | A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV-1 Nef protein |
| Q35699707 | APOBEC3G levels predict rates of progression to AIDS |
| Q21245213 | Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypes |
| Q30176465 | Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques |
| Q39872863 | Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection |
| Q36015423 | CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable |
| Q39875549 | Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. |
| Q30175327 | Conservation of the central proline-rich (PxxP) motifs of human immunodeficiency virus type 1 Nef protein during the disease progression in two hemophiliac patients |
| Q24336554 | Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain |
| Q35841354 | Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus |
| Q34302168 | Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. |
| Q33429049 | Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics |
| Q39579134 | Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. |
| Q39872268 | Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression. |
| Q33837307 | Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates |
| Q36845893 | Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes |
| Q35885977 | Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo |
| Q35888785 | Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. |
| Q39578202 | Grossly defective nef gene sequences in a human immunodeficiency virus type 1-seropositive long-term nonprogressor |
| Q40961265 | HIV preventive vaccines. Progress to date |
| Q33591503 | HIV vaccines. |
| Q34033160 | HIV-1 Nef: a critical factor in viral-induced pathogenesis |
| Q24676982 | HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors |
| Q71200441 | HLA and natural history of HIV infection |
| Q37372729 | Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors |
| Q35872157 | High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. |
| Q35157534 | Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products |
| Q36155465 | Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo |
| Q34340441 | Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors |
| Q28246575 | Influence of microbial infections on the progression of HIV disease |
| Q34648909 | Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection |
| Q33966626 | Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101 |
| Q40947468 | Long-term survivors of HIV-1 infection |
| Q45737944 | Low or no antibody responses to human immunodeficiency virus type 1 Nef in infected carriers with subtype E, in contrast to subtype B that showed antibodies preferentially recognizing subtype-specific Nef epitopes |
| Q36238124 | Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations |
| Q33828507 | Mechanisms of Virologic Control and Clinical Characteristics of HIV+ Elite/Viremic Controllers |
| Q33725746 | Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression |
| Q93167836 | Myosin-X is essential to the intercellular spread of HIV-1 Nef through tunneling nanotubes |
| Q34056459 | Natural history of HIV-1 infection |
| Q24817186 | Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification |
| Q49587948 | Nef Secretion into Extracellular Vesicles or Exosomes Is Conserved across Human and Simian Immunodeficiency Viruses. |
| Q35139327 | Nef alleles from human immunodeficiency virus type 1-infected long-term-nonprogressor hemophiliacs with or without late disease progression are defective in enhancing virus replication and CD4 down-regulation |
| Q41142054 | Nef and the Nef-associated kinase |
| Q33851483 | Nef-induced CD4 downregulation: a diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. |
| Q92713448 | Nef-mediated inhibition of NFAT following TCR stimulation differs between HIV-1 subtypes |
| Q39579672 | Persistent antibody responses but declining cytotoxic T-lymphocyte responses to multiple human immunodeficiency virus type 1 antigens in a long-term nonprogressing individual with a defective p17 proviral sequence and no detectable viral RNA express |
| Q34010283 | Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis |
| Q39581871 | Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor |
| Q37099665 | Predicting the impact of blocking human immunodeficiency virus type 1 Nef in vivo |
| Q30176097 | Regions of human immunodeficiency virus type 1 nef required for function in vivo |
| Q36496515 | Relative Resistance of HLA-B to Downregulation by Naturally Occurring HIV-1 Nef Sequences |
| Q39871310 | Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence |
| Q30156825 | Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation |
| Q33815169 | Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease |
| Q39877474 | Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons. |
| Q47735179 | The HIV-1 Nef protein enhances the affinity of reverse transcriptase for RNA in vitro. |
| Q33599913 | The debate on the presence of HIV-1 in human gametes |
| Q39595906 | The human immunodeficiency virus type 1 nef gene can to a large extent replace simian immunodeficiency virus nef in vivo. |
| Q35882911 | The nef gene products of both simian and human immunodeficiency viruses enhance virus infectivity and are functionally interchangeable. |
| Q30329411 | The past, present and future of HIV-vaccine development: a critical view. |
| Q28647550 | The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase |
| Q64234590 | Weighted lambda superstrings applied to vaccine design |
Search more.